Zdravka Poljaković

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 281 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex

Sonja Stahl, Sabine Gaetzner, Bettina Brackertz et al. · Human Mutation · 2008 · 112 citations

Life Sciences, Molecular Genetics, Neurology +17

A Prospective, Randomized, Placebo-Controlled, Double-Blind Trial about Safety and Efficacy of Combined Treatment with Alteplase (rt-PA) and Cerebrolysin in Acute Ischaemic Hemispheric Stroke

Wilfried Lang, Christian H. Stadler, Zdravka Poljaković et al. · International Journal of Stroke · 2012 · 107 citations

Medicine, Neurology, Pharmacotherapy +17

Economic Evaluation of Pharmacogenomic-Guided Warfarin Treatment for Elderly Croatian Atrial Fibrillation Patients with Ischemic Stroke

Christina Mitropoulou, V. Fragoulakis, Nada Božina et al. · Pharmacogenomics · 2015 · 62 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Giulio Francesco Romiti, Bernadette Corica, Marco Proietti et al. · EClinicalMedicine · 2023 · 43 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17